SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043295
Filing Date
2018-08-09
Accepted
2018-08-09 16:17:03
Documents
101
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499568_10q.htm 10-Q 1138972
2 EXHIBIT 31.1 tv499568_ex31-1.htm EX-31.1 10578
3 EXHIBIT 31.2 tv499568_ex31-2.htm EX-31.2 10323
4 EXHIBIT 32.1 tv499568_ex32-1.htm EX-32.1 4317
5 EXHIBIT 32.2 tv499568_ex32-2.htm EX-32.2 4282
  Complete submission text file 0001144204-18-043295.txt   12138306

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fbio-20180630.xml EX-101.INS 3658461
7 XBRL TAXONOMY EXTENSION SCHEMA fbio-20180630.xsd EX-101.SCH 107956
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20180630_cal.xml EX-101.CAL 73845
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20180630_def.xml EX-101.DEF 660855
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20180630_lab.xml EX-101.LAB 683466
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20180630_pre.xml EX-101.PRE 710252
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 181005255
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences